KOOTENAI HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

Phase 4

Withdrawn

Conditions: SARS-CoV-2 Pneumonia
COVID-19

Interventions: Drug: Hydroxychloroquine

First Posted Date: 2020-05-11

Last Posted Date: 2021-02-05

Lead Sponsor: Kootenai Health

Registration Number: NCT04382625

Locations: 🇺🇸
Kootenai Health, Coeur d'Alene, Idaho, United States

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

Phase 4

Completed

Conditions: Total Hip and Knee Arthroplasty

Interventions: Drug: Liposomal Bupivacaine
Drug: Ropivacaine
Drug: Bupivacaine
Drug: Clonidine
Drug: Epinephrine
Drug: Ketorolac

First Posted Date: 2015-09-07

Last Posted Date: 2019-10-18

Lead Sponsor: Kootenai Health

Target Recruit Count: 239

Registration Number: NCT02543801

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy